Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 7 studies | 22% ± 9% | |
epithelial cell | 6 studies | 32% ± 9% | |
CD8-positive, alpha-beta memory T cell | 5 studies | 17% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 23% ± 6% | |
squamous epithelial cell | 4 studies | 37% ± 20% | |
B cell | 4 studies | 21% ± 5% | |
classical monocyte | 4 studies | 31% ± 14% | |
gamma-delta T cell | 4 studies | 23% ± 7% | |
plasmacytoid dendritic cell | 4 studies | 18% ± 3% | |
T cell | 3 studies | 16% ± 1% | |
CD8-positive, alpha-beta T cell | 3 studies | 28% ± 11% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 27% ± 7% | |
non-classical monocyte | 3 studies | 45% ± 16% | |
ciliated cell | 3 studies | 25% ± 7% | |
basal cell | 3 studies | 27% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1835.98 | 966 / 966 | 100% | 18.80 | 527 / 527 |
uterus | 100% | 998.54 | 170 / 170 | 100% | 19.93 | 459 / 459 |
esophagus | 100% | 2326.73 | 1444 / 1445 | 100% | 16.55 | 183 / 183 |
bladder | 100% | 1314.29 | 21 / 21 | 100% | 23.25 | 502 / 504 |
prostate | 100% | 1534.13 | 245 / 245 | 100% | 10.68 | 500 / 502 |
ovary | 100% | 863.26 | 180 / 180 | 100% | 11.38 | 428 / 430 |
stomach | 100% | 1729.49 | 358 / 359 | 100% | 15.92 | 285 / 286 |
lung | 99% | 1422.48 | 575 / 578 | 100% | 17.41 | 1153 / 1155 |
thymus | 100% | 1307.04 | 652 / 653 | 99% | 10.87 | 601 / 605 |
skin | 100% | 1859.68 | 1809 / 1809 | 99% | 12.36 | 468 / 472 |
pancreas | 100% | 935.27 | 327 / 328 | 99% | 21.58 | 177 / 178 |
breast | 100% | 1076.66 | 458 / 459 | 99% | 13.75 | 1108 / 1118 |
liver | 100% | 958.22 | 226 / 226 | 98% | 10.68 | 397 / 406 |
brain | 96% | 853.28 | 2543 / 2642 | 100% | 10.64 | 705 / 705 |
kidney | 100% | 1251.99 | 89 / 89 | 96% | 9.60 | 862 / 901 |
adrenal gland | 100% | 1021.90 | 258 / 258 | 94% | 6.48 | 216 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.68 | 29 / 29 |
spleen | 100% | 2796.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.90 | 1 / 1 |
adipose | 100% | 978.93 | 1201 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2655.38 | 923 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 921.57 | 1325 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 6.02 | 73 / 80 |
heart | 84% | 409.28 | 725 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 363.93 | 535 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0006281 | Biological process | DNA repair |
GO_0010821 | Biological process | regulation of mitochondrion organization |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0007129 | Biological process | homologous chromosome pairing at meiosis |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0006974 | Biological process | DNA damage response |
GO_0106230 | Biological process | protein depropionylation |
GO_0006476 | Biological process | protein deacetylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0061698 | Biological process | protein deglutarylation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0010526 | Biological process | retrotransposon silencing |
GO_1901836 | Biological process | regulation of transcription of nucleolar large rRNA by RNA polymerase I |
GO_2000234 | Biological process | positive regulation of rRNA processing |
GO_0045722 | Biological process | positive regulation of gluconeogenesis |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0062176 | Biological process | R-loop processing |
GO_0036049 | Biological process | peptidyl-lysine desuccinylation |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0036047 | Biological process | peptidyl-lysine demalonylation |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0046825 | Biological process | regulation of protein export from nucleus |
GO_0009303 | Biological process | rRNA transcription |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0005730 | Cellular component | nucleolus |
GO_0005731 | Cellular component | nucleolus organizer region |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0003682 | Molecular function | chromatin binding |
GO_0036055 | Molecular function | protein-succinyllysine desuccinylase activity |
GO_0061697 | Molecular function | protein-glutaryllysine deglutarylase activity |
GO_0106231 | Molecular function | protein-propionyllysine depropionylase activity |
GO_0036054 | Molecular function | protein-malonyllysine demalonylase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0034979 | Molecular function | NAD-dependent protein lysine deacetylase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008276 | Molecular function | protein methyltransferase activity |
GO_0097372 | Molecular function | NAD-dependent histone H3K18 deacetylase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SIRT7 |
Protein name | Regulatory protein SIR2 homolog 7 (SIR2-like protein 7) NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7) Sirtuin 7 |
Synonyms | SIR2L7 |
Description | FUNCTION: NAD-dependent protein-lysine deacylase that can act both as a deacetylase or deacylase (desuccinylase, depropionylase, deglutarylase and dedecanoylase), depending on the context . Specifically mediates deacetylation of histone H3 at 'Lys-18' (H3K18Ac) . In contrast to other histone deacetylases, displays strong preference for a specific histone mark, H3K18Ac, directly linked to control of gene expression . H3K18Ac is mainly present around the transcription start site of genes and has been linked to activation of nuclear hormone receptors; SIRT7 thereby acts as a transcription repressor . Moreover, H3K18 hypoacetylation has been reported as a marker of malignancy in various cancers and seems to maintain the transformed phenotype of cancer cells . Also able to mediate deacetylation of histone H3 at 'Lys-36' (H3K36Ac) in the context of nucleosomes . Also mediates deacetylation of non-histone proteins, such as ATM, CDK9, DDX21, DDB1, FBL, FKBP5/FKBP51, GABPB1, RAN, RRP9/U3-55K and POLR1E/PAF53 . Enriched in nucleolus where it stimulates transcription activity of the RNA polymerase I complex . Acts by mediating the deacetylation of the RNA polymerase I subunit POLR1E/PAF53, thereby promoting the association of RNA polymerase I with the rDNA promoter region and coding region . In response to metabolic stress, SIRT7 is released from nucleoli leading to hyperacetylation of POLR1E/PAF53 and decreased RNA polymerase I transcription . Required to restore the transcription of ribosomal RNA (rRNA) at the exit from mitosis . Promotes pre-ribosomal RNA (pre-rRNA) cleavage at the 5'-terminal processing site by mediating deacetylation of RRP9/U3-55K, a core subunit of the U3 snoRNP complex . Mediates 'Lys-37' deacetylation of Ran, thereby regulating the nuclear export of NF-kappa-B subunit RELA/p65 . Acts as a regulator of DNA damage repair by mediating deacetylation of ATM during the late stages of DNA damage response, promoting ATM dephosphorylation and deactivation . Suppresses the activity of the DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes by mediating deacetylation of DDB1, which prevents the interaction between DDB1 and CUL4 (CUL4A or CUL4B) . Activates RNA polymerase II transcription by mediating deacetylation of CDK9, thereby promoting 'Ser-2' phosphorylation of the C-terminal domain (CTD) of RNA polymerase II . Deacetylates FBL, promoting histone-glutamine methyltransferase activity of FBL . Acts as a regulator of mitochondrial function by catalyzing deacetylation of GABPB1 (By similarity). Regulates Akt/AKT1 activity by mediating deacetylation of FKBP5/FKBP51 . Required to prevent R-loop-associated DNA damage and transcription-associated genomic instability by mediating deacetylation and subsequent activation of DDX21, thereby overcoming R-loop-mediated stalling of RNA polymerases . In addition to protein deacetylase activity, also acts as a protein-lysine deacylase . Acts as a protein depropionylase by mediating depropionylation of Osterix (SP7), thereby regulating bone formation by osteoblasts (By similarity). Acts as a histone deglutarylase by mediating deglutarylation of histone H4 on 'Lys-91' (H4K91glu); a mark that destabilizes nucleosomes by promoting dissociation of the H2A-H2B dimers from nucleosomes . Acts as a histone desuccinylase: in response to DNA damage, recruited to DNA double-strand breaks (DSBs) and catalyzes desuccinylation of histone H3 on 'Lys-122' (H3K122succ), thereby promoting chromatin condensation and DSB repair . Also promotes DSB repair by promoting H3K18Ac deacetylation, regulating non-homologous end joining (NHEJ) (By similarity). Along with its role in DNA repair, required for chromosome synapsis during prophase I of female meiosis by catalyzing H3K18Ac deacetylation (By similarity). Involved in transcriptional repression of LINE-1 retrotransposon via H3K18Ac deacetylation, and promotes their association with the nuclear lamina . Required to stabilize ribosomal DNA (rDNA) heterochromatin and prevent cellular senescence induced by rDNA instability . Acts as a negative regulator of SIRT1 by preventing autodeacetylation of SIRT1, restricting SIRT1 deacetylase activity (By similarity). . |
Accessions | I3L2A4 ENST00000572902.5 Q9NRC8 ENST00000328666.11 [Q9NRC8-1] I3L480 ENST00000575360.5 |